Anthera Pharmaceuticals Inc (NASDAQ:ANTH)

0.3345
Delayed Data
As of Apr 20
 -0.0065 / -1.91%
Today’s Change
0.30
Today|||52-Week Range
3.39
-79.73%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues0.003.2M145.0K0.00
 
 
 
Depreciation And Amortization344.0K285.0K266.0K281.0K
 
 
 
 
 
 
Operating ExpensesGross Income-344.0K-----281.0K
 
 
 
General Expenses28.1M40.8M57.3M36.3M
 
 
 
 
 
Research And Development21.8M33.5M46.5M28.6M
 
 
 
 
 
Total Operating Expenses28.5M41.1M57.6M36.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-28.5M-37.9M-57.4M-36.5M
 
 
 
 
 
Extraordinary Credit0.000.001.7M9.6M
 
 
 
Interest Expense On Debt1.0M0.000.000.00
 
 
Other Expenses-96.0K2.7M171.0K15.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-29.6M-35.2M-55.5M-26.9M
 
 
 
 
 
Preferred Dividend0.000.00-10.9M-2.5M
 
 
 
Net Income-29.6M-35.2M-55.5M-26.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS2.7M4.5M5.2M10.3M
 
 
 
 
 
Shares To Calculate EPS Diluted2.7M4.5M5.2M10.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$10.88-$7.92-$12.88-$2.86
 
 
 
 
 
EPS Diluted-$10.88-$7.92-$12.88-$2.86